SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 120 filers reported holding SUTRO BIOPHARMA INC in Q2 2024. The put-call ratio across all filers is 138.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $87,868 | +43.2% | 29,989 | +176.2% | 0.01% | +100.0% |
| Q1 2024 | $61,348 | -73.3% | 10,858 | -79.7% | 0.00% | -80.0% |
| Q4 2023 | $229,665 | +249.5% | 53,535 | +182.7% | 0.02% | +275.0% |
| Q3 2023 | $65,704 | -53.2% | 18,935 | -37.2% | 0.00% | -55.6% |
| Q2 2023 | $140,300 | -1.4% | 30,172 | -2.0% | 0.01% | 0.0% |
| Q1 2023 | $142,241 | -8.6% | 30,788 | +59.9% | 0.01% | +12.5% |
| Q4 2022 | $155,597 | +2122.8% | 19,257 | +2651.0% | 0.01% | – |
| Q3 2020 | $7,000 | +133.3% | 700 | +75.0% | 0.00% | – |
| Q2 2020 | $3,000 | 0.0% | 400 | +33.3% | 0.00% | – |
| Q1 2020 | $3,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q4 2019 | $3,000 | -75.0% | 300 | -77.1% | 0.00% | -100.0% |
| Q3 2019 | $12,000 | +20.0% | 1,312 | +44.2% | 0.00% | – |
| Q2 2019 | $10,000 | – | 910 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $41,527,000 | 15.56% |
| Samsara BioCapital, LLC | 1,675,579 | $38,136,000 | 7.03% |
| First Light Asset Management, LLC | 2,058,447 | $46,850,000 | 3.11% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $22,792,000 | 1.83% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,983,000 | 1.50% |
| Altium Capital Management LP | 226,719 | $5,160,000 | 1.43% |
| Opaleye Management Inc. | 341,950 | $7,783,000 | 1.14% |
| Parkman Healthcare Partners LLC | 202,696 | $4,613,000 | 1.07% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 139,331 | $3,171,000 | 0.84% |
| Eventide Asset Management | 2,370,975 | $53,963,000 | 0.80% |